Gerhardy Benjamin, Sivapathan Shanthosh, Bowcock Emma, Orde Sam, Morgan Lucy
Department of Intensive Care Medicine, Nepean Hospital, Kingswood, NSW, Australia.
Nepean Clinical School, University of Sydney School of Medicine, Sydney, NSW, Australia.
J Intensive Care Med. 2024 Mar;39(3):203-216. doi: 10.1177/08850666231218713. Epub 2023 Dec 6.
Right ventricular dysfunction (RVD) is common in the critically ill. To date studies exploring RVD sequelae have had heterogenous definitions and diagnostic methods, with limited follow-up. Additionally much literature has been pathology specific, limiting applicability to the general critically unwell patient.
We conducted a systematic review and meta-analysis to evaluate the impact of RVD diagnosed with transthoracic echocardiography (TTE) on long-term mortality in unselected critically unwell patients compared to those without RVD. A systematic search of EMBASE, Medline and Cochrane was performed from inception to March 2022. All RVD definitions using TTE were included. Patients were those admitted to a critical or intensive care unit, irrespective of disease processes. Long-term mortality was defined as all-cause mortality occurring at least 30 days after hospital admission. A priori subgroup analyses included disease specific and delayed mortality (death after hospital discharge/after the 30 day from hospital admission) in patients with RVD. A random effects model analysis was performed with the Dersimionian and Laird inverse variance method to generate effect estimates.
Of 5985 studies, 123 underwent full text review with 16 included (n = 3196). 1258 patients had RVD. 19 unique RVD criteria were identified. The odds ratio (OR) for long term mortality with RVD was 2.92 (95% CI 1.92-4.54, 76.4%) compared to no RVD. The direction and extent was similar for cardiac and COVID19 subgroups. Isolated RVD showed an increased risk of delayed mortality when compared to isolated left/biventricular dysfunction (OR 2.01, 95% CI 1.05-3.86, 46.8%).
RVD, irrespective of cause, is associated with increased long term mortality in the critically ill. Future studies should be aimed at understanding the pathophysiological mechanisms by which this occurs. Commonly used echocardiographic definitions of RVD show significant heterogeneity across studies, which contributes to uncertainty within this dataset.
右心室功能障碍(RVD)在危重症患者中很常见。迄今为止,探索RVD后遗症的研究在定义和诊断方法上存在异质性,随访也有限。此外,许多文献针对特定病理,限制了其对一般危重症患者的适用性。
我们进行了一项系统综述和荟萃分析,以评估经胸超声心动图(TTE)诊断的RVD对未选择的危重症患者长期死亡率的影响,并与无RVD的患者进行比较。从数据库建立到2022年3月,对EMBASE、Medline和Cochrane进行了系统检索。纳入所有使用TTE的RVD定义。患者为入住重症监护病房的患者,无论疾病过程如何。长期死亡率定义为入院至少30天后发生的全因死亡率。预先设定的亚组分析包括RVD患者的疾病特异性和延迟死亡率(出院后/入院30天后死亡)。采用Dersimionian和Laird逆方差法进行随机效应模型分析以生成效应估计值。
在5985项研究中,123项进行了全文审查,16项被纳入(n = 3196)。1258例患者患有RVD。确定了19种独特的RVD标准。与无RVD相比,RVD患者长期死亡率的比值比(OR)为2.92(95%CI 1.92 - 4.54,76.4%)。心脏亚组和新冠病毒疾病亚组的方向和程度相似。与孤立的左心室/双心室功能障碍相比,孤立的RVD显示延迟死亡风险增加(OR 2.01,95%CI 1.05 - 3.86,46.8%)。
无论病因如何,RVD与危重症患者长期死亡率增加相关。未来的研究应旨在了解其发生的病理生理机制。常用的超声心动图RVD定义在各研究中显示出显著的异质性,这导致了该数据集中的不确定性。